Important role of lymphovascular and perineural invasion in prognosis of colorectal cancer patients with N1c disease

doi:10.3748/wjg.v31.i5.102210

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (655)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

329

Figures (1-3)

Tables (1-3)

Sum=505

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=117

Feb 7, 2025 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 7, 2025; 31(5): 102210
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102210

Full Size Figure Download Figure

Figure 2 Three groups divided according to presence of lymphovascular invasion and perineural invasion had different prognosis. A: Predicting disease-free survival (P < 0.0001); B: Predicting overall survival (P < 0.0001); C: Predicting cancer-specific survival (P < 0.0001). LVI: Lymphovascular invasion; PNI: Perineural invasion.

Citation: Sun ZG, Chen SX, Sun BL, Zhang DK, Sun HL, Chen H, Hu YW, Zhang TY, Han ZH, Wu WX, Hou ZY, Yao L, Jie JZ. Important role of lymphovascular and perineural invasion in prognosis of colorectal cancer patients with N1c disease. World J Gastroenterol 2025; 31(5): 102210
URL: https://www.wjgnet.com/1007-9327/full/v31/i5/102210.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i5.102210